IRIS
CAPUANO, ROCCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 129
NA - Nord America 110
AS - Asia 37
Totale 276
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 108
IT - Italia 53
IE - Irlanda 51
SG - Singapore 30
DE - Germania 12
NL - Olanda 6
CN - Cina 5
CA - Canada 2
FI - Finlandia 2
GB - Regno Unito 2
AT - Austria 1
BE - Belgio 1
BG - Bulgaria 1
HK - Hong Kong 1
TR - Turchia 1
Totale 276
Salva come PNG Salva come JPEG
Città #
Dublin 49
Santa Clara 30
Singapore 27
New York 20
Naples 16
Chandler 14
Aversa 5
Amsterdam 4
Bremen 4
Cambridge 4
Munich 4
Princeton 4
Roxbury 4
Boardman 3
Rome 3
Sala Consilina 3
Trentola-Ducenta 3
Beijing 2
Caserta 2
London 2
Trecase 2
Andover 1
Bacoli 1
Boydton 1
Brussels 1
Frankfurt am Main 1
Helsinki 1
Hong Kong 1
Istanbul 1
Krimpen Aan Den Ijssel 1
Lappeenranta 1
Los Angeles 1
L’Aquila 1
Menlo Park 1
Milan 1
Nuremberg 1
Ottawa 1
Quarto 1
Romola 1
Salerno 1
Sofia 1
Toronto 1
Turin 1
Verona 1
Vienna 1
Wilmington 1
Totale 230
Salva come PNG Salva come JPEG
Nome #
The psychological impact of Covid-19 pandemic on people with Multiple Sclerosis: A meta-analysis 40
Six-month humoral response to BNT162b2 mRNA COVID-19 vaccine in people with multiple sclerosis treated with natalizumab 38
Six-month humoral response to mRNA SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab and fingolimod 37
Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod 26
Multicenter data harmonization for regional brain atrophy and application in multiple sclerosis 25
Oligoclonal IgM bands in the cerebrospinal fluid of patients with relapsing MS to inform long-term MS disability 23
Epidemiologic Data of Vitamin D Deficiency and Its Implication in Cardio-Cerebrovascular Risk in a Southern Italian Population 18
Efficacy and safety of tixagevimab-cilgavimab (Evusheld®) in people with Multiple Sclerosis on Ocrelizumab: preliminary evidence 15
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study 15
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context 12
Impact of post-contrast MRI in the definition of active multiple sclerosis 12
Adding the Optic Nerve in Multiple Sclerosis Diagnostic Criteria: A Longitudinal, Prospective, Multicenter Study 12
Post-contrast MRI in multiple sclerosis: Towards a judicious use of gadolinium-based contrast agents 12
Symptomatic COVID-19 course and outcomes after three mRNA vaccine doses in multiple sclerosis patients treated with high-efficacy DMTs 8
Quality of care provided by Multiple Sclerosis Centers during Covid-19 pandemic: Results of an Italian multicenter patient-centered survey 8
Totale 301
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.341
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.341
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202227 0 0 0 0 0 0 0 0 5 2 11 9
2022/202383 6 0 0 3 11 7 0 5 43 5 1 2
2023/202499 3 3 8 7 21 23 1 2 5 0 12 14
2024/202592 2 0 0 22 68 0 0 0 0 0 0 0
Totale 301